The COVID-19 inflammation and high mortality mechanism trigger
S Stróż, P Kosiorek, A Stasiak-Barmuta - Immunogenetics, 2024 - Springer
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) lasted from March 2020 to May 2023, infecting over 689 million and causing …
(SARS-CoV-2) lasted from March 2020 to May 2023, infecting over 689 million and causing …
Host genetic factors determining COVID-19 susceptibility and severity
TP Velavan, SR Pallerla, J Rüter, Y Augustin… - …, 2021 - thelancet.com
The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) poses an unprecedented challenge to humanity. SARS-CoV-2 infections …
(SARS-CoV-2) poses an unprecedented challenge to humanity. SARS-CoV-2 infections …
The long COVID syndrome: A conundrum for the allergist/immunologist
JA Bellanti - Allergy and Asthma Proceedings, 2022 - ingentaconnect.com
Background: The long coronavirus disease 2019 (COVID-19) syndrome includes a group of
patients who, after infection with severe acute respiratory syndrome coronavirus 2 (SARS …
patients who, after infection with severe acute respiratory syndrome coronavirus 2 (SARS …
Unraveling the mystery surrounding post-acute sequelae of COVID-19
RK Ramakrishnan, T Kashour, Q Hamid… - Frontiers in …, 2021 - frontiersin.org
More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
A Al-Musa, B LaBere, S Habiballah, AA Nguyen… - Journal of Allergy and …, 2022 - Elsevier
Our understanding of risk factors and interventions influencing outcomes from coronavirus
disease 2019 (COVID-19) has continued to evolve, revealing advances emerging from …
disease 2019 (COVID-19) has continued to evolve, revealing advances emerging from …
Environmental variation and genetic diversity contribute to population differences in immune responses to SARS-CoV-2 and COVID-19 risk
M Rotival, L Quintana-Murci - Genes & Immunity, 2023 - nature.com
The COVID-19 pandemic has brought to light considerable clinical variation among
individuals infected with SARS-CoV-2, ranging from asymptomatic cases to fatal outcome …
individuals infected with SARS-CoV-2, ranging from asymptomatic cases to fatal outcome …
Analysis of genetic host response risk factors in severe COVID-19 patients
ABSTRACT BACKGROUND Epidemiological studies indicate that as many as 20% of
individuals who test positive for COVID-19 develop severe symptoms that can require …
individuals who test positive for COVID-19 develop severe symptoms that can require …
COVID-19 as an acute inflammatory disease
RH Manjili, M Zarei, M Habibi… - The journal of immunology, 2020 - journals.aai.org
Abstract The 2019 coronavirus disease (COVID-19) pandemic caused by the virus severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created an unprecedented …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created an unprecedented …
[HTML][HTML] Human genetics of SARS-CoV-2 infection and critical COVID-19
TH Mogensen - Clinical Microbiology and Infection, 2022 - Elsevier
Background During the past 2 years, studies on patients with SARS-CoV-2 infection have
revealed rare inborn errors of immunity (IEIs) in type interferon (IFN) pathways underlying …
revealed rare inborn errors of immunity (IEIs) in type interferon (IFN) pathways underlying …
[HTML][HTML] The first 12 months of COVID-19: a timeline of immunological insights
Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …
China, in December 2019, the novel coronavirus that causes this disease—severe acute …